Cargando…
Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (S...
Autores principales: | Marin, I., Rydèn, T., Van Essen, M., Svensson, J., Gracheva, N., Köster, U., Zeevaart, J. R., van der Meulen, N. P., Müller, C., Bernhardt, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329978/ https://www.ncbi.nlm.nih.gov/pubmed/32613587 http://dx.doi.org/10.1186/s40658-020-00314-x |
Ejemplares similares
-
Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
por: Borgna, Francesca, et al.
Publicado: (2021) -
Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy
por: Gracheva, Nadezda, et al.
Publicado: (2019) -
Dosimetric Analysis of the Short-Ranged Particle Emitter (161)Tb for Radionuclide Therapy of Metastatic Prostate Cancer
por: Bernhardt, Peter, et al.
Publicado: (2021) -
Terbium-161 for PSMA-targeted radionuclide therapy of
prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019) -
EVALUATION OF THE SPATIAL RESOLUTION IN MONTE CARLO-BASED SPECT/CT RECONSTRUCTION OF (111)IN-OCTREOTIDE IMAGES
por: Wikberg, Emma, et al.
Publicado: (2021)